GlassScriptPhysician profile
Mateusz Graca
NPI 1154982502
$9,714.96
in general payments reported to CMS, 2019-2025
19 companies · $5,006 in 2025
The $5,006 reported for 2025 was more than what 91% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $36.53 · 2021: $103 · 2023: $1,395 · 2024: $3,175 · 2025: $5,006.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,710 · Travel and Lodging: $2,843 · Education: $22.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,709.97 |
| Travel and Lodging | $2,843.08 |
| Education | $22.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,604.11 | 2024-2025 | Proclaim, Eterna, Axium |
| Boston Scientific Corporation | $1,054.77 | 2024-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Nalu Medical, INC. | $611.39 | 2023-2024 | Nalu Neurostimulation System |
| Spinal Simplicity, LLC | $593.81 | 2024-2025 | Ha Minuteman G3-R |
| Medtronic, INC. | $554.78 | 2023-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Synchromedii |
| Nevro Corp. | $534.05 | 2023-2024 | Senza, Vyrsa V1 |
| Globus Medical, INC. | $474.03 | 2025 | Senza, Omnia |
| Spr Therapeutics, INC | $263.33 | 2023-2025 | Sprint Pns System |
| Abbvie INC. | $184.70 | 2021-2024 | |
| Vb Spine LLC | $163.86 | 2025 | Everest Spinal System |
| Curonix LLC | $129.77 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Merz Pharmaceuticals, LLC | $125.00 | 2023 | Xeomin |
| Averitas Pharma INC. | $119.30 | 2023 | Qutenza |
| Tersera Therapeutics LLC | $93.85 | 2025 | Prialt |
| Saluda Medical Americas, INC. | $84.59 | 2024-2025 | Evoke |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $48.97 | 2024-2025 | Evenity, Prolia, Prolia |
| Avanos Medical | $36.53 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $20.90 | 2025 | |
| Merck Sharp & Dohme LLC | $17.22 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mateusz Graca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.